Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia

• Status: Completed
• Trial end date: 2005-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to assess the safety and efficacy of fluvastatin in children diagnosed with heterozygous familial hypercholesterolemia

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novartis
• Treatments: Fluvastatin

Criteria

Inclusion Criteria:

• 10-16 years old Heterozygous familial hypercholesterolemia

Exclusion Criteria:

• Homozygous familial hypercholesterolemia Pregnant or lactating females Major surgery during the six month prior study

Other protocol defined inclusion and exclusion criteria may apply